Together Pharma Ltd
TGPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $28,605 | $25,315 | $17,212 | $16,924 |
| - Cash | $3,592 | $5,296 | $5,095 | $5,758 |
| + Debt | $54,803 | $58,675 | $84,754 | $57,223 |
| Enterprise Value | $79,816 | $78,694 | $96,871 | $68,389 |
| Revenue | $91,006 | $31,228 | $12,026 | $11,223 |
| % Growth | 191.4% | 159.7% | 7.2% | – |
| Gross Profit | $34,622 | -$5,888 | -$2,173 | -$5,839 |
| % Margin | 38% | -18.9% | -18.1% | -52% |
| EBITDA | $27,616 | -$14,368 | -$6,138 | $20,555 |
| % Margin | 30.3% | -46% | -51% | 183.2% |
| Net Income | -$4,316 | -$33,524 | -$13,776 | $7,152 |
| % Margin | -4.7% | -107.4% | -114.6% | 63.7% |
| EPS Diluted | -0.49 | -4.11 | -2.01 | 1.24 |
| % Growth | 88.1% | -104.5% | -262.1% | – |
| Operating Cash Flow | $14,831 | -$13,733 | -$18,644 | -$9,703 |
| Capital Expenditures | -$866 | -$333 | -$1,530 | -$13,752 |
| Free Cash Flow | $13,965 | -$14,066 | -$20,174 | -$23,455 |